Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma
Conditions
Gastric Cancer · Esophagogastric Junction Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Hao Xu, MD (Sub-investigator)Hongda Liu (Sub-investigator)